Advanced company searchLink opens in new window

EPIRUS BIOPHARMACEUTICALS LIMITED

Company number 07504850

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
26 Oct 2012 TM01 Termination of appointment of Diljeet Athwal as a director
29 Feb 2012 AR01 Annual return made up to 25 January 2012 with full list of shareholders
29 Feb 2012 TM01 Termination of appointment of Manish Chapekar as a director
14 Nov 2011 AP01 Appointment of Daniel Kay Turner Iii as a director
16 Sep 2011 AP01 Appointment of Dr Diljeet Singh Athwal as a director
11 Apr 2011 AP01 Appointment of Scott Michael Rocklage as a director
11 Apr 2011 AP01 Appointment of Manish Narendra Chapekar as a director
11 Apr 2011 AP01 Appointment of Elliot Goldstein as a director
11 Apr 2011 AP01 Appointment of Geoffrey Duyk as a director
11 Apr 2011 TM01 Termination of appointment of Richard Bursby as a director
11 Apr 2011 TM01 Termination of appointment of Huntsmoor Nominees Limited as a director
11 Apr 2011 TM01 Termination of appointment of Huntsmoor Limited as a director
09 Mar 2011 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of Memorandum and/or Articles of Association
27 Jan 2011 AA01 Current accounting period shortened from 31 January 2012 to 31 December 2011
25 Jan 2011 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted